Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedle Fractional Radiofrequency with Topical Insulin for Facial Atrophic Acne Scars
TCTR20211203003Phase 3Recruiting
- Sponsor
- Division of Dermatology, Ramathibodi Hospital, Mahidol University
- Start
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human insulin in atrophic acne scar, sponsored by Division of Dermatology, Ramathibodi Hospital, Mahidol University. Started Nov 2021; status: recruiting.
02
Drugs
human insulin
03
Conditions
atrophic acne scar
Beyond the preview
Go deeper on TCTR20211203003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211203003.